Evidence map›Paper›PMID 28091953›Full record

ArticleNanoscale research letters2017

Fullerene C

D Franskevych, K Palyvoda, D Petukhov, S Prylutska, I Grynyuk, C Schuetze, L Drobot, O Matyshevska, U Ritter

Open access · goldAbstract read
In one paragraph

Article in Nanoscale research letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. ZrOJournal of functional biomaterials · 2026
    Article
  3. Article
  4. Review
  5. Fullerene CInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Silent Death by Sound: CInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Anticoronavirus Activity of Water-Soluble Pristine CAdvances in experimental medicine and biology · 2021
    Article
  15. A Multiparametric Study of Internalization of Fullerenol CInternational journal of molecular sciences · 2020
    Article
  16. Effects of Pristine CDigestive diseases and sciences · 2020
    Article
  17. CPharmaceutics · 2019
    Article
  18. Synergy of Chemo- and Photodynamic Therapies with CNanomaterials (Basel, Switzerland) · 2019
    Article
  19. A Novel Nanoconjugate of Landomycin A with CCellular and molecular bioengineering · 2019
    Article
  20. Mechano-signalling, induced by fullerene CInternational journal of nanomedicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

D FranskevychNational Taras Shevchenko University of Kyiv, 64/13 Volodymyrska Street, Kyiv, 01601, Ukraine. dashaqq@gmail.com.ORCID http://orcid.org/0000-0002-1719-0512
K PalyvodaNational Taras Shevchenko University of Kyiv, 64/13 Volodymyrska Street, Kyiv, 01601, Ukraine.
D PetukhovPalladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 9 Leontovicha Street, Kyiv, 01030, Ukraine.
S PrylutskaNational Taras Shevchenko University of Kyiv, 64/13 Volodymyrska Street, Kyiv, 01601, Ukraine.
I GrynyukNational Taras Shevchenko University of Kyiv, 64/13 Volodymyrska Street, Kyiv, 01601, Ukraine.
C SchuetzeIlmenau University of Technology, 29 Ehrenbergstrasse, Ilmenau, 98693, Germany.
L DrobotPalladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 9 Leontovicha Street, Kyiv, 01030, Ukraine.
O MatyshevskaNational Taras Shevchenko University of Kyiv, 64/13 Volodymyrska Street, Kyiv, 01601, Ukraine.
U RitterIlmenau University of Technology, 29 Ehrenbergstrasse, Ilmenau, 98693, Germany.
Taras Shevchenko National University of Kyiv · UANational Academy of Sciences of Ukraine · UATechnische Universität Ilmenau · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fullerene C

Indexed as

Drug resistanceFullerene C60Leukemic cellsMitochondrial membrane potentialPhotodynamic therapyProtein tyrosine phosphorylation

Identifiers

PMID28091953
PMCPMC5236044
OpenAlexW2579513976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.